Search En menu en ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages
Reference: 20220170
Release date: 13 April 2023

Promoter – Financial Intermediary

DEK VACCINES LTD

Location

Description

The project consists in a grant facility of up to EUR 5m providing seed financing to support the construction, furnishing and validation of a fill and finish vaccine manufacturing facility in the suburbs of Accra, Ghana.

Objectives

The facility will initially target vaccines that are a priority for the African continent and is expected to contribute to enhanced regional independence in health security.

Sector(s)

Proposed EIB finance (Approximate amount)

EUR 5 million

Total cost (Approximate amount)

EUR 47 million

Environmental aspects

The promoter is required to implement the project in accordance with the EIB's Environmental and Social Policy and Standards.

Procurement

The promoter is required to implement the project in accordance with the EIB's Guide to Procurement.

Status

Signed - 29/03/2023

Milestone
Under appraisal
Approved
Signed
27 March 2023
29 March 2023

Disclaimer

Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

Related tags

Regional - West Africa Industry